2 and 3 are provided in Supplementary Data 23 and 24, respectively
Exp Diabetes Res 2012;2012:924168
In clinical trials, specific agents have demonstrated significant benefits in glycemic control, with some (liraglutide, semaglutide, and dulaglutide) showing cardiovascular risk reduction in dedicated outcome trials
This suggests that in addition to greater persistence, more patients can regularly take medication as prescribed throughout the year in more recent years as well
Quick math for common doses at 2.5 mg/mL: 0.25 mg: 0.25 / 2.5 x 100 = 10 units 0.50 mg: 0.50 / 2.5 x 100 = 20 units 1.0 mg: 1.0 / 2.5 x 100 = 40 units 1.7 mg: 1.7 / 2.5 x 100 = 68 units 2.4 mg: 2.4 / 2.5 x 100 = 96 units If you reconstituted with 3.0 mL instead (1.67 mg/mL), the same doses become 15, 30, 60, 102, and 144 units respectively
SHOP NOW Our Community Blog Find everything you need to know about your supplements from our blog